Your session is about to expire
← Back to Search
Heated Chemotherapy for Metastatic Pancreatic Cancer
Study Summary
This trial is testing the effects of chemotherapy that is heated and placed directly in the abdomen on patients with pancreatic cancer that has spread to the internal abdominal area.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My test for KRAS mutation in abdominal fluid is positive.My cancer has spread to the lining of my abdomen and tests confirm it.My cancer spread is limited, confirmed by a surgical exam.Your platelet count is at least 60,000 per microliter.My cancer markers or scans improved after chemotherapy.I am between 18 and 80 years old.My surgeon believes all visible cancer can likely be removed, and my PCI score is 7 or less.My cancer has spread to organs like the liver, brain, or lungs.I can follow the study's requirements and attend all appointments.You have enough white blood cells called neutrophils in your body.I do not have infections like pneumonia that would stop me from following the treatment plan.I am not pregnant, can avoid breastfeeding, and will use effective birth control.I've had a severe allergic reaction to chemotherapy before.My diagnosis is pancreatic adenocarcinoma.I can take care of myself and am up and about more than 50% of my waking hours.Your white blood cell count is at least 3,000 per microliter.Your blood creatinine level is not higher than 1.5 mg/dL.
- Group 1: Treatment (HIPEC)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the standard reason that patients receive Hyperthermic Intraperitoneal Chemotherapy?
"lg-utuc, head and neck carcinoma, and cervical cancers can all be treated with Hyperthermic Intraperitoneal Chemotherapy."
What is the official stance of the FDA on Hyperthermic Intraperitoneal Chemotherapy?
"While there is some data supporting the safety of Hyperthermic Intraperitoneal Chemotherapy, it only received a score of 2 because there is no clinical evidence yet demonstrating its efficacy."
Are there any past case studies of Hyperthermic Intraperitoneal Chemotherapy?
"There are presently 804 studies underway studying Hyperthermic Intraperitoneal Chemotherapy. Of these, 308 are live clinical trials in Phase 3. Not limited to one city, 45246 locations around the world are running studies for this treatment; though many of the investigations into Hyperthermic Intraperitoneal Chemotherapy originate from Shanghai, China."
Are there any current openings for participants in this research?
"The clinical trial is not presently looking for participants. The study was first posted on 10/15/2022 and was last updated on 8/3/2022. While this study is not recruiting candidates at this time, there are 1404 other studies that are."
Are there any inclusion or exclusion criteria for potential participants of this research?
"This study is looking for 40 individuals that have stage iv pancreatic cancer ajcc v8 and are between 18-80 years old. The most crucial inclusion criteria are as follows: Age >= 18 but =< 80, Eastern Cooperative Oncology Group (ECOG) performance status =< 2, Cytologic or histologic proof of adenocarcinoma of the pancreas, Leukocytes >= 3,000/uL, Absolute neutrophil count >= 1,500/uL, Platelets >= 60,000/Ul, Serum creatinine =< 1.5 mg/dL,"
Will this research allow elderly participants?
"According to the eligibility requirements listed, individuals between 18-80 years old are qualified to apply for this clinical trial. There are 87 trials available for minors and 1346 studies seeking senior participants."
What is the projected participant pool for this research?
"This study is no longer recruiting patients for the trial. The clinical trial was originally posted on 10/15/2022 and was most recently edited on 8/3/2022. However, there are currently 600 other clinical trials actively enrolling patients with stage iv pancreatic cancer ajcc v8 and 804 studies for Hyperthermic Intraperitoneal Chemotherapy that participants can explore."
Share this study with friends
Copy Link
Messenger